Skip to main content
Clinical Trials/NCT00713986
NCT00713986
Completed
Phase 3

Non-Pharmacologic Interventions to Relief Pain in Healthy Newborns Submitted to Vaccination to Hepatitis B: a Comparison Between Skin-to-Skin Contact, Glucose 25% and Both of Them

Federal University of São Paulo0 sites640 target enrollmentMarch 2006
ConditionsPainAnalgesia

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Pain
Sponsor
Federal University of São Paulo
Enrollment
640
Primary Endpoint
Neonatal pain scales: Neonatal infant pain Scale (NIPS), Neonatal Facial Coding System (NFCS) and Premature Infant Pain Profile (PIPP)
Status
Completed
Last Updated
17 years ago

Overview

Brief Summary

Acute procedural pain in neonates may be alleviated by non-pharmacological procedures. This study objective is to test the efficacy regarding pain attenuation of 3 interventions (skin-to-skin contact versus glucose 25% versus skin to skin associated to glucose 25) versus control in healthy newborn infants submitted to intra-muscular vaccination for Hepatitis B at 48-72 hours of life.

Registry
clinicaltrials.gov
Start Date
March 2006
End Date
July 2008
Last Updated
17 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Federal University of São Paulo

Eligibility Criteria

Inclusion Criteria

  • Written informed consent.
  • Gestational age of 37 0/7 to 41 6/7 weeks.
  • Patients cared in rooming-in, with post-natal age of 12 to 72 hours of life.
  • Adequate for gestational age and healthy infants.
  • No other painful stimuli before study except for Vitamine K injection soon after birth.
  • Interval from last feeding between 30 and 60 minutes.

Exclusion Criteria

  • Mothers that used opioid at gestation labor or birth.
  • Delivery under general anesthesia.
  • Apgar score less than seven in the 1st or 5th minute of life.
  • Neonates that received any venous, arterial, capillary or spinal puncture.
  • Any congenital malformation or CNS abnormality.

Outcomes

Primary Outcomes

Neonatal pain scales: Neonatal infant pain Scale (NIPS), Neonatal Facial Coding System (NFCS) and Premature Infant Pain Profile (PIPP)

Time Frame: before the pain procedure (atrest), during cleaning of the region, at injection, and 2 minutes after injection

Secondary Outcomes

  • Physiologic pain assessment variables: heart rate and oxygen saturation(before the pain procedure (atrest), during cleaning of the region, at injection, and 2 minutes after injection)

Similar Trials